Eli Lilly Responses to NYT Articles on Zyprexa Misconduct

Point of Law notes that Eli Lilly has responded to the New York Times articles discussing Zyprexa misconduct.  Here are links to Eli Lilly’s response to the 12/17 NYT article, Eli Lilly’s response to the 12/18 NYT article, and Eli Lilly’s response to the 12/21 NYT article.

BGS